No humans allowed: Alex Zhavoronkov adds robotic lab to his AI drug discovery play as Insilico unveils $60M raise

For Alex Zhavoronkov, the recent biotech market downturn is, in fact, a good thing.

The Insilico CEO — in his signature confident exuberance — said the crisis …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

No hu­mans al­lowed: Alex Zha­voronkov adds ro­bot­ic lab to his AI drug dis­cov­ery play as In­sil­i­co un­veils $60M raise